Deciding whether human genes should be patented

Disclosure: This coverage is more of a blog style post. This week we highlight an ongoing topic in the scientific realm that I think is interesting and important from a researcher’s point of view, solely. It does not explore the commercial perspective, simply because the company—Myriad Genetics—did not respond to my email request for comment. The scoop A couple weeks ago, the Supreme Court added a case to its docket to review the future patenting of human genes. Myriad … [Read more...]